Rocket Pharmaceuticals (RCKTW) Competitors $0.10 +0.02 (+25.00%) (As of 09/18/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends RCKTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, ACABU, BCAX, BFRIW, and BTMDWShould you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Bicara Therapeutics (BCAX), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. Rocket Pharmaceuticals vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Bicara Therapeutics Biofrontera biote Rocket Pharmaceuticals (NASDAQ:RCKTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends. Is RCKTW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Rocket PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor RCKTW or ATNFW? In the previous week, Rocket Pharmaceuticals had 8 more articles in the media than 180 Life Sciences. MarketBeat recorded 10 mentions for Rocket Pharmaceuticals and 2 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.44 beat Rocket Pharmaceuticals' score of 0.39 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Rocket Pharmaceuticals Neutral 180 Life Sciences Positive Does the MarketBeat Community favor RCKTW or ATNFW? Rocket Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformRocket PharmaceuticalsN/AN/A180 Life SciencesN/AN/A Which has preferable earnings & valuation, RCKTW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRocket PharmaceuticalsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Do analysts recommend RCKTW or ATNFW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rocket Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryRocket Pharmaceuticals and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Ad Porter & CompanyWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.Click here to learn how you can benefit from its widespread distribution. Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCKTW vs. The Competition Export to ExcelMetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$187.42M$5.68B$8.27BDividend YieldN/A3.44%4.34%4.08%P/E RatioN/A303.76143.7418.58Price / SalesN/A12,577.501,618.6173.18Price / CashN/A12.2537.1831.90Price / BookN/A6.844.854.56Net IncomeN/A-$25.33M$115.00M$223.87M7 Day PerformanceN/A-0.36%4.41%5.73%1 Month PerformanceN/A4.87%9.61%9.09%1 Year PerformanceN/A12.56%29.39%12.63% Rocket Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATNFW180 Life Sciences0 of 5 stars0.00 / 5 stars$0.01-19.2%N/A-45.1%$0.00N/A0.007Positive NewsGap UpLBPSW4D pharma0 of 5 stars0.00 / 5 stars$0.04-25.7%N/AN/A$0.00$522,000.000.00N/AGap DownAEHAWAesther Healthcare Acquisition0 of 5 stars0.00 / 5 stars$0.16+6.2%N/AN/A$0.00N/A0.002Gap UpAIMDWAinos0 of 5 stars0.00 / 5 stars$0.05-27.0%N/A-66.9%$0.00$65,122.000.0040Positive NewsALVOWAlvotech0 of 5 stars0.00 / 5 stars$2.55+2.0%N/AN/A$0.00$306.77M0.004Positive NewsACABWAtlantic Coastal Acquisition Corp. II0 of 5 stars0.00 / 5 stars$0.04-11.1%N/A-14.4%$0.00N/A0.004Positive NewsGap DownHigh Trading VolumeACABUAtlantic Coastal Acquisition Corp. II0 of 5 stars0.00 / 5 stars$10.99-1.9%N/AN/A$0.00N/A0.004Positive NewsBCAXBicara Therapeutics0 of 5 stars0.00 / 5 stars$23.41-10.8%N/AN/A$0.00N/A0.0032Insider BuyingNews CoverageNegative NewsHigh Trading VolumeBFRIWBiofrontera0 of 5 stars0.00 / 5 stars$0.03-20.5%N/A-32.3%$0.00$35.24M0.0070Gap DownBTMDWbiote0 of 5 stars0.00 / 5 stars$1.61+15.8%N/A-69.8%$0.00$187.23M0.00N/AGap Up Related Companies and Tools Related Companies: ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives ACABU Alternatives BCAX Alternatives BFRIW Alternatives BTMDW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RCKTW) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
